Economic analysis of automated insulin delivery (AID) systemsOur aim is to determine if automated insulin delivery (AID) systems provide good value compared with standard insulin delivery. We will support the external validation of a computer simulation model (Swedish National Diabetes Register T1D model) which will then be used to estimate the long-term cost-effectiveness (from the US healthcare system and payer perspective) of AID systems versus standard therapy among T1D patients. This is a collaboration among DOR, University of Michigan, Jaeb Center for Health Research, and University of Oxford.
Investigator: Karter, Andrew
Funder: The Leona M. and Harry B. Helmsley Charitable Trust